Rasio rega marang bathi clene.com (CLNN)
This daily price chart for Clene Inc. (CLNN), which has a PE ratio of -2.40, illustrates the business development of its neuroprotector pipeline. Supply chain reliability is ensured by a specialized temperature regime and field protection during the transport of medications. The company's resilience to economic cycles is driven by its focus on clinical trials. High brand authority among ALS patients and shareholder confidence are based on the innovative nanocrystalline platform.
Rincian analitis perusahaan Clene Inc (CLNN)
- nilai saham lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- informasi kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Utang marang Modal Clene Inc.|CLNN - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Clene Nanomedicine|CLNN - Gunggung utang perusahaan|Utang-utang marang aset resik Clene Inc.|CLNN - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Clene|Indikator likuiditas cepet clene.com
- data bathi bisnis lan rasio investasi:
CLNN - Penghasilan resik|Prakiraan bathi perusahaan Clene Inc.|CLNN - Pangali P/E|Prakiraan rega marang bathi Clene Nanomedicine|CLNN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Clene Inc.|CLNN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Clene|CLNN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan clene.com|CLNN - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Clene Inc.
Ringkesan analisis perusahaan:Clene Inc.
The P/E ratio determines the market value of a business relative to its annual net income, measuring the investment payback period and the valuation's sensitivity to financial statements. The P/E valuation trend for Clene Inc. (CLNN) on the GURU.Markets platform reflects market expectations for the company's nanoparticle patents, where high metric volatility underscores the speculative potential of biopharmaceutical developments for treating neurodegeneration.
Analisis perusahaan pesaing
Koefisien rega marang bathi biogen.com (BIIB)|Rasio rega marang bathi Neurocrine Biosciences, Inc. (NBIX)|Rasio rega marang bathi RGC (Regencell Bioscience Ltd)|Pangali P/E AXSM (Axsome Therapeutics Inc)|ACADIA Corp (ACAD) - Kapitalisasi marang bathi|XENE - Rasio rega marang bathi|VKTX (vikingtherapeutics.com) - Pangali rega marang bathi|SUPN: Pangali P/E|Kapitalisasi marang bathi Catalyst Pharma (CPRX)|Koefisien rega marang bathi DNLI|HRMY: Nilai perusahaan marang bathi resik|Pangali P/E BHVN|Periode bali modal bisnis amylyx.com|Rasio rega marang bathi Trevi Therapeutics, Inc. TRVI|PRAX: Pangali rega marang bathi|Anavex Corp - Pangali P/E|CeriBell EEG (CBLL) - Koefisien rega marang bathi|PRTA (prothena.com) - Koefisien rega marang bathi|ALEC - Periode bali modal bisnis|ANNX (Annexon) - Pangali P/E|Koefisien rega marang bathi Omeros Corp. (OMER)|Rasio rega marang bathi Neurogene Corp (NGNE)|Rasio rega marang bathi ACIU (AC Immune Inc)|Rasio rega marang bathi Voyager Therapeutics VYGR|NMRA: Pangali rega marang bathi|SCLX - Rasio rega marang bathi|TVGN (Tevogen Bio Holdings Inc.) - Pangali rega marang bathi|alphacognition.com (ACOG) - Rasio rega marang bathi|Pangali rega marang bathi CGTX|IKT (Inhibikase Therapeutics) - Pangali P/E|Kapitalisasi marang bathi cassavasciences.com SAVA|Koefisien rega marang bathi ASRT (Assertio Holdings, Inc.)|Pangali P/E coyatherapeutics.com (COYA)|Rasio rega marang bathi Vistagen VTGN|Nilai perusahaan marang bathi resik OVID|ABOS - Rasio rega marang bathi|Kapitalisasi marang bathi cervomed.com|ATHE: Pangali P/E|Koefisien rega marang bathi PepGen|Rasio rega marang bathi Jupiter Neurosciences|Rasio rega marang bathi RLMD|Pangali P/E ANVS|GRCE - Kapitalisasi marang bathi|Rasio rega marang bathi Firefly Neuroscience AIFF|KLTO: Pangali rega marang bathi|NeuroSense Therapeutics, Ltd. - Pangali P/E|Kapitalisasi marang bathi Reviva Pharmaceuticals, Inc.|MTVA (metaviatx.com) - Koefisien rega marang bathi|neuraxis.com - Nilai perusahaan marang bathi resik|HSDT (Helius Medical Technologies, Inc.) - Pangali P/E|Passage Bio Corp (PASG) - Periode bali modal bisnis|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|Minerva - Pangali rega marang bathi|Pangali P/E ATHA (Athira Pharma, Inc.)|ADXN - Koefisien rega marang bathi|ALZN: Koefisien rega marang bathi|Periode bali modal bisnis Cyclerion Therapeutics CYCN|PTIX: Pangali P/E|Koefisien rega marang bathi Pasithea Therapeutics Corp.|Rasio rega marang bathi Cortigent Inc|Rasio rega marang bathi ATXI|Rasio rega marang bathi BrainStorm Cell Therapeutics (BCLI)|Cara Therapeutics Inc. - Pangali rega marang bathi|Rasio rega marang bathi Chromocell Therapeutics Corporation CHRO|ELYM: Pangali rega marang bathi|ITCI - Rasio rega marang bathi|LBPH (longboardpharma.com) - Pangali rega marang bathi|MRNS: Pangali P/E|Kapitalisasi marang bathi NKGen Biotech Inc (NKGN)|Koefisien rega marang bathi NRBO|Pangali P/E Sage Therapeutics Inc|Rasio rega marang bathi Synaptogenix, Inc. (SNPX)|TRVN (trevena.com) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|anewmeds.com (WENA) - Kapitalisasi marang bathi|Cerevel - Pangali P/E
